Suppr超能文献

一种内皮素B受体选择性拮抗剂:IRL 1038,[半胱氨酸11-半胱氨酸15]-内皮素-1(11-21)

An endothelin B receptor-selective antagonist: IRL 1038, [Cys11-Cys15]-endothelin-1(11-21).

作者信息

Urade Y, Fujitani Y, Oda K, Watakabe T, Umemura I, Takai M, Okada T, Sakata K, Karaki H

机构信息

International Research Laboratories, CIBA-GEIGY Ltd., Takarazuka, Japan.

出版信息

FEBS Lett. 1992 Oct 12;311(1):12-6. doi: 10.1016/0014-5793(92)81355-p.

Abstract

In the inhibition of specific binding of [125I]endothelins (ETs) to membrane from various tissues of rats, guinea pigs, pigs and humans, [Cys11-Cys15]-ET-1(11-21), IRL 1038, has a much higher affinity for ETB receptors (Ki = 6-11 nM) than for ETA receptors (Ki = 0.4-0.7 microM). In contraction assays, with ET-3 as a stimulant, 3 microM IRL 1038 antagonized the ETB receptor-mediated contraction of guinea pig ileal and tracheal smooth muscle without any significant agonistic activity, but did not effect the ETA receptor-mediated contraction of rat aortic smooth muscle. IRL 1038 is therefore, considered to be the first antagonist selective to the ETB receptor.

摘要

在抑制[125I]内皮素(ETs)与大鼠、豚鼠、猪和人类各种组织的细胞膜特异性结合方面,[Cys11 - Cys15]-ET-1(11 - 21),即IRL 1038,对ETB受体的亲和力(Ki = 6 - 11 nM)远高于对ETA受体的亲和力(Ki = 0.4 - 0.7 microM)。在收缩试验中,以ET - 3作为刺激剂,3 microM的IRL 1038拮抗了ETB受体介导的豚鼠回肠和气管平滑肌收缩,且无任何明显的激动活性,但对ETA受体介导的大鼠主动脉平滑肌收缩无影响。因此,IRL 1038被认为是首个对ETB受体具有选择性的拮抗剂。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验